ARS Pharmaceuticals (SPRY) Intangibles: 2023-2025
Historic Intangibles for ARS Pharmaceuticals (SPRY) over the last 2 years, with Sep 2025 value amounting to $14.7 million.
- ARS Pharmaceuticals' Intangibles rose 96.39% to $14.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.7 million, marking a year-over-year increase of 96.39%. This contributed to the annual value of $7.4 million for FY2024, which is 1094.65% up from last year.
- As of Q3 2025, ARS Pharmaceuticals' Intangibles stood at $14.7 million, which was up 13.54% from $13.0 million recorded in Q2 2025.
- Over the past 5 years, ARS Pharmaceuticals' Intangibles peaked at $14.7 million during Q3 2025, and registered a low of $446,000 during Q2 2024.
- In the last 3 years, ARS Pharmaceuticals' Intangibles had a median value of $7.3 million in 2024 and averaged $6.4 million.
- Data for ARS Pharmaceuticals' Intangibles shows a peak YoY skyrocketed of 2,808.52% (in 2025) over the last 5 years.
- Quarterly analysis of 3 years shows ARS Pharmaceuticals' Intangibles stood at $617,000 in 2023, then soared by 1,094.65% to $7.4 million in 2024, then spiked by 96.39% to $14.7 million in 2025.
- Its Intangibles stands at $14.7 million for Q3 2025, versus $13.0 million for Q2 2025 and $7.2 million for Q1 2025.